BILL ANALYSIS

HR7540

BULLISH

United States-Israel FUTURES Act of 2026

HR7540 (United States-Israel FUTURES Act of 2026) has been assessed with a bullish outlook for investors. The primary sectors impacted are Defense and Technology. View the full bill text on Congress.gov.

bullish

Market Sentiment

4/10

Impact Score

Sectors Impacted

Key Takeaways for Investors

HR7540 is an authorization bill that creates a framework for U.S.-Israel defense tech cooperation, but no money is attached yet; actual revenue depends on future appropriations.

The bill directly benefits defense primes with existing Israeli partnerships: $LMT, $RTX, $NOC, and to a lesser extent $BA.

With 50 cosponsors and a Senate companion bill, passage probability is above average for a new authorization, but the impact is moderate (score 4) due to the early stage and lack of funding details.

How HR7540 Affects the Market

The bill reinforces the long-term U.S. government commitment to Israel's qualitative military edge and joint defense R&D, which supports the defense sector's top-line growth narrative. Among primes, $LMT and $RTX have the most direct exposure through existing Israeli co-production programs. $NOC benefits from the 'emerging technologies' language. is a positive but lower-conviction beneficiary due to its financial constraints. The lack of a specific appropriation means the market impact is limited to sentiment and mid-term contract visibility. No real market data on price movements is available for this bill, but historical patterns show defense authorization bills produce modest, gradual positive drift for exposed contractors.

Bill Details

Metric	Value
Bill Number	HR7540
Market Sentiment	bullish
Event Date	February 12, 2026
Affected Sectors	Defense, Technology
Source	View on Congress.gov →

Summary

The United States-Israel FUTURES Act of 2026 (HR7540) is a bipartisan bill early in the legislative process that authorizes a new Defense Technology Cooperation Initiative, signaling continued strong U.S.-Israel defense collaboration. The bill does not specify funding levels, but it creates a framework for joint R&D and technology integration that directly benefits prime defense contractors with existing Israel partnerships, particularly Lockheed Martin ($LMT), Raytheon ($RTX), and Northrop Grumman ($NOC). The absence of a companion appropriation and the bill's early referral to committees limit near-term revenue visibility, but the structural tailwind for defense primes is clear.

Full AI Market Analysis

**What happened:** On February 12, 2026, Rep. Ronny Jackson (R-TX) introduced HR7540, the United States-Israel FUTURES Act, which was referred to the House Armed Services and Foreign Affairs Committees. The bill establishes a sense of Congress that the U.S.-Israel defense partnership should be expanded, and creates a formal 'United States-Israel Defense Technology Cooperation Initiative' to accelerate joint development and integration of Israeli-origin defense technologies into U.S. systems. This is an authorization bill—it sets policy and spending ceilings but does not appropriate money. Actual funding requires a separate appropriations bill. A companion bill, S3855, has been introduced in the Senate and referred to the Foreign Relations Committee, increasing the likelihood of eventual passage. **The money trail:** The bill does not authorize a specific dollar amount. Section 3 establishes the initiative but leaves funding to future appropriations. Historically, similar U.S.-Israel cooperative programs (e.g., Arrow, Iron Dome co-production) have received annual appropriations in the $500M-$1B range. The bill's primary market impact is to signal long-term government commitment to deepening defense ties, which supports revenue visibility for contractors already involved in joint programs. Because this is a first-step authorization, the immediate financial impact is zero, but the legislative path suggests incremental contract opportunities over the next 2-4 years. **Structural winners and losers:** The primary beneficiaries are defense primes with established U.S.-Israel joint ventures. Lockheed Martin ($LMT) is the prime for the F-35 and Arrow missile defense; Raytheon ($RTX) co-produces Iron Dome and David's Sling; Northrop Grumman ($NOC) has partnerships in electronic warfare and space. Boeing has a smaller but present role in unmanned systems and directed energy. The bill's emphasis on 'rapid integration' favors companies with existing Israeli collaborations over those without. There are no direct losers, but legacy platforms that do not incorporate Israeli technology may see reduced relative priority. **Timeline and legislative path:** The bill is in early stage (referred to committees). With bipartisan support (50 cosponsors) and a Senate companion, it has momentum. The next steps are committee hearings, markups, and a floor vote. Given the 119th Congress runs through 2027, passage could occur in 2026 or 2027. If enacted, the initiative would be implemented over several years, with contracts likely awarded starting in 2027-2028.